Diprivan and Hyperparathyroidism - a phase IV clinical study of FDA data

Summary:

Hyperparathyroidism is reported as a side effect among people who take Diprivan (propofol), especially for people who are female, 50-59 old, also take Plavix, and have Hypercalcaemia of malignancy.

The phase IV clinical study analyzes which people have Hyperparathyroidism when taking Diprivan. It is created by eHealthMe based on reports of 6,477 people who have side effects when taking Diprivan from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Hyperparathyroidism?

Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium) is found to be associated with 455 drugs and 445 conditions by eHealthMe. Check the latest studies of Hyperparathyroidism.

On Jul, 17, 2026

6,477 people reported to have side effects when taking Diprivan.
Among them, 12 people (0.19%) have Hyperparathyroidism.

Could Diprivan cause Hyperparathyroidism?

Among these 12 people:

What is the gender of people who have Hyperparathyroidism when taking Diprivan? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Hyperparathyroidism when taking Diprivan? *

What are other drugs people take besides Diprivan? *

What are other side effects people have besides Hyperparathyroidism? *

X-Ray Abnormal: 11 people, 91.67%
Enlarged Heart: 11 people, 91.67%
Extremity Necrosis (death of body tissue of arms and legs): 11 people, 91.67%
Facial Pain: 11 people, 91.67%
Hearing Loss: 11 people, 91.67%
Heart Disease: 11 people, 91.67%
Hepatic Enzyme Abnormal: 11 people, 91.67%
Hip Fracture: 11 people, 91.67%
Hyperkalemia (damage to or disease of the kidney): 11 people, 91.67%
Hypokalemia (low potassium): 11 people, 91.67%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 91.67%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 11 people, 91.67%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 6 people, 50.00%
Vitamin B12 Deficiency: 1 person, 8.33%
Rickets (softening of bones): 1 person, 8.33%
Pain: 1 person, 8.33%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and have Hyperparathyroidism?

- Check whether Hyperparathyroidism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diprivan:

Diprivan (6,496 reports)

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperparathyroidism:

Hyperparathyroidism (455 drugs)

Browse all the conditions that are associated with Hyperparathyroidism:

Hyperparathyroidism (445 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on propofol (the active ingredients of Diprivan) and Diprivan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.